Skip to main content

Table 6 Studies reporting anal human papillomavirus (HPV) infection in cancer-free men in Europea

From: Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review

Author, year

Country

Population

Sample size

Sampling techniques and detection methods

HPV (%)

     

Any

95%CI

Van der Snoek, 2003 [40]

The

Netherlands

MSM

HIV+ and HIV-

258

(17 HIV+, 241 HIV-)

Swabs

PCR + LiPA

64.7 (HIV+)

32.8 (HIV-)

(38.33-85.79)

(27.06-38.94)

Pierangeli, 2008 [56]

Italy

MSM and

HS (HIV+ and HIV-)

61

(36 HIV+,

25 HIV-)

Anal brushing

PCR

81.6 (HIV+)

68.0 (HIV-)

(63.98-91.81)

(46.50-85.05)

Sirera, 2006 [52]

Spain

HIV+ men

(MSM and HS)

74

(52 MSM

22 HS)

Cytobrush

PCR

82.6 (MSM)

68.2 (HS)

(69.67-91.77)

(45.13-86.14)

Piketty, 2003 [51]

France

HIV+ men

(MSM and HSiDU)

118

(67 MSM, 50 HSiDU)

Swabs

PCR

85.1(MSM)

46.0 (HSiDU)

(74.26-92.60)

(31.81-60.68)

Van Doornum, 1994 [49]

The

Netherlands

STD clinic attendees

85

Cotton swabs or wooden spatula

15.3

(8.40-24.73)

Löwhagen, 1999 [50]

Sweden

STD clinic attendees (HIV+ and HIV- MSM)

30

(17 HIV+,

13 HIV-)

Cotton swabs

PCR

76.7

94.1 (HIV+)

53.8 (HIV-)

(61.5-91.8)

(82.9-100.0)

(26.7-80.9)

  1. CI confidence interval, MSM men who have sex with men, STD sexually transmitted disease, HS heterosexual, HSiDU heterosexual intravenous drug user, STD sexually transmitted disease
  2. a 26 European countries